PURE Bioscience, Inc. (PURE) Reports Q3 Loss of $0.05, Revenues Fall Year-Over-Year
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
Tweet
Share
E-mailGet Alerts PURE Hot Sheet
Price: $0.08 +14.29%
Financial Fact:
Research and development: 248K
Today's EPS Names:
CFFI, ZGN, SSNC, More
Financial Fact:
Research and development: 248K
Today's EPS Names:
CFFI, ZGN, SSNC, More
Join SI Premium – FREE
PURE Bioscience, Inc. (NASDAQ: PURE) reported Q3 EPS of ($0.05), versus ($0.05) reported last year. Revenue for the quarter came in at $128.4 thousand, versus $536.5 thousand reported last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pharming Group N.V. (PHAR) Reports Q3 results; offers guidance
- Southern Missouri Bancorp (SMBC) Tops Q1 EPS by 7c
- Medpace beats Q3 estimates but guides below on revenue
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
